Research programme: Crohn's disease therapeutics - Verge Genomics
Latest Information Update: 09 Feb 2024
Price :
$50 *
At a glance
- Originator Verge Genomics
- Class Anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Crohn's disease
Most Recent Events
- 22 Dec 2023 Early research in Crohn's disease in USA (unspecified route), prior to December 2023 (Verge Genomics pipeline, December 2023)